Wealth Enhancement Advisory Services
SEM

Wealth Enhancement Advisory Services’s Select Medical SEM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,877
Closed -$84.1K – 4213
2026
Q1 		$84.1K Buy
15,877
+9,844
+163% +$154K ﹤0.01% 3352
2025
Q4 		$95.2K Buy
6,033
+545
+10% +$7.7K ﹤0.01% 3438
2025
Q3 		$71.6K Sell
5,488
-5,567
-50% -$74.2K ﹤0.01% 3382
2025
Q2 		$167K Buy
+11,055
New +$172K ﹤0.01% 3035
2024
Q3 		– Sell
-12,131
Closed -$229K – 2904
2024
Q2 		$229K Buy
+12,131
New +$207K ﹤0.01% 2193

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Wealth Enhancement Advisory Services's SEM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Select Medical (SEM) in Q2 2026, closing a stake of 15,877 shares — an estimated $84.1K sold.

Wealth Enhancement Advisory Services first reported a position in SEM in Q2 2024 and held it in 5 quarters. The position peaked at $229K in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 15,877 Select Medical shares in Q2 2026, an estimated $84.1K.
  • Wealth Enhancement Advisory Services first reported a position in Select Medical in Q2 2024 and held it in 5 quarters.
  • Wealth Enhancement Advisory Services's Select Medical position peaked at $229K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.